Migraine and Women’s Health
Pfizer and the American Headache Society (AHS) are collaborating to offer a new grant opportunity inviting proposals for collaborative quality improvement and research projects focused on migraine and women’s health. This Request for Proposals (RFP) aims to foster high-impact research and initiatives that advance scientific understanding, improve patient outcomes, and address gaps in care. Projects should also contribute to the core goal of the AHS – improving the lives of people impacted by migraine and other headache disorders.
For all quality improvement, Investigator Sponsored Research (ISRs), and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the quality improvement or research program. An ISR grant request cannot be submitted for a study that has already commenced and was not originally supported by Pfizer.
|
Date RFP Issued: March 9, 2026 Geographic Scope: United States Clinical Area: Pain – Migraine Link to full RFP: Migraine and Women’s Health Letter of Intent (LOI) Submission Due Date: May 5, 2026 Specific Area of Interest: The goals of this Request for Proposals are:
|
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.